Intercell Receives Manufacturer's Licence for Future Commercial Manufacturing of its Vaccine Against Japanese Encephalitis
Intercell receives Manufacturer's Licence for its site in Livingston, Scotland
18-Jan-2008 -
Intercell AG announced that its fully owned manufacturing site in Livingston, Scotland (Intercell Biomedical Ltd.), has been granted the Manufacturer's Licence for the commercial manufacturing of its vaccine against Japanese Encephalitis. The issuance of the license is following a GMP (Good ...
food
Intercell
Japanese encephalitis